Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Saijo, N' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 192 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kanzawa, F; Koizumi, F; Koh, Y; Nakamura, T; Tatsumi, Y; Fukumoto, H; Saijo, N; Yoshioka, T; Nishio, K
      In vitro synergistic interactions between the cisplatin analogue nedaplatin and the DNA topoisomerase I inhibitor irinotecan and the mechanism of this interaction

      CLINICAL CANCER RESEARCH
    2. Sekine, I; Saijo, N
      Polymorphisms of metabolizing enzymes and transporter proteins involved inthe clearance of anticancer agents

      ANNALS OF ONCOLOGY
    3. Tatsumi, Y; Arioka, H; Ikeda, S; Fukumoto, H; Miyamoto, K; Fukuoka, K; Ohe, Y; Saijo, N; Nishio, K
      Enhancement of in vivo antitumor activity of a novel antimitotic 1-phenylpropenone derivative, AM-132, by tumor necrosis factor-alpha or interleukin-6

      JAPANESE JOURNAL OF CANCER RESEARCH
    4. Nakamura, T; Koizumi, F; Kaneko, N; Tamura, T; Chiwaki, F; Koh, Y; Akutagawa, S; Saijo, N; Nishio, K
      Reversal of cisplatin resistance by the 1,4-benzothiazepine derivative, JTV-519

      JAPANESE JOURNAL OF CANCER RESEARCH
    5. Shimizu, M; Tamura, T; Yamada, Y; Akiyama, Y; Saijo, N; Nishio, K
      CPT-11 alters the circadian rhythm of dihydropyrimidine dehydrogenase mRNAin mouse liver

      JAPANESE JOURNAL OF CANCER RESEARCH
    6. Inoue, A; Saijo, N
      Recent advances in the chemotherapy of non-small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    7. Kurata, T; Tamura, T; Shinkai, T; Ohe, Y; Kunitoh, H; Kodama, T; Kakinuma, R; Matsumoto, T; Kubota, K; Omatsu, H; Nishiwaki, Y; Saijo, N
      Phase I and pharmacological study of paclitaxel given over 3 h with cisplatin for advanced non-small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    8. Ohe, Y; Niho, S; Kakinuma, R; Kubota, K; Matsumoto, T; Ohmatsu, H; Goto, K; Kunitoh, H; Saijo, N; Nishiwaki, Y
      Phase I studies of cisplatin and docetaxel administered by three consecutive weekly infusions for advanced non-small cell lung cancer in elderly and non-elderly patients

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    9. Akiyama, Y; Ohe, Y; Tamura, T; Sawada, M; Inoue, A; Kusaba, H; Yamamoto, N; Sekine, I; Kunitoh, H; Kodama, T; Saijo, N
      A dose escalation study of paclitaxel and carboplatin in untreated Japanese patients with advanced non-small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    10. Tsuchiya, S; Ohe, Y; Sugiura, T; Fuwa, N; Kitamoto, Y; Mori, K; Kobayashi, H; Nakata, K; Sawa, T; Hirai, K; Etoh, T; Saka, H; Saito, A; Fukuda, H; Ishizuka, N; Saijo, N
      Randomized phase I study of standard-fractionated or accelerated-hyperfractionated radiotherapy with concurrent cisplatin and vindesine for unresectable non-small cell lung cancer: a report of Japan Clinical Oncology Group Study (JCOG 9601)

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    11. Inoue, A; Kunitoh, H; Sekine, I; Sumi, M; Tokuuye, K; Saijo, N
      Radiation pneumonitis in lung cancer patients: A retrospective study of risk factors and the long-term prognosis

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    12. Saijo, N; Tamura, T; Yamamoto, N; Nishio, K
      New strategies for cancer therapy in the 21st century

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    13. Tsunoda, T; Nakamura, T; Ishimoto, K; Yamaue, H; Tanimura, H; Saijo, N; Nishio, K
      Upregulated expression of angiogenesis genes and down regulation of cell cycle genes in human colorectal cancer tissue determined by cDNA macroarray

      ANTICANCER RESEARCH
    14. Kunitoh, H; Akiyama, Y; Kusaba, H; Yamamoto, N; Sekine, I; Ohe, Y; Kubota, K; Tamura, T; Shinkai, T; Kodama, T; Goto, K; Niho, S; Nishiwaki, Y; Saijo, N
      A phase I/II trial of cisplatin, docetaxel and ifosfamide in advanced or recurrent non-small cell lung cancer

      LUNG CANCER
    15. Natsume, T; Nakamura, T; Koh, Y; Kobayashi, M; Saijo, N; Nishio, K
      Gene expression profiling of exposure to TZT-1027, a novel microtubule-interfering agent, in non-small cell lung cancer PC-14 cells and astrocytes

      INVESTIGATIONAL NEW DRUGS
    16. Fukuoka, K; Usuda, J; Iwamoto, Y; Fukumoto, H; Nakamura, T; Yoneda, T; Narita, N; Saijo, N; Nishio, K
      Mechanisms of action of the novel sulfonamide anticancer agent E7070 on cell cycle progression in human non-small cell lung cancer cells

      INVESTIGATIONAL NEW DRUGS
    17. Greco, FA; Saijo, N
      Current perspectives in the treatment of small cell lung cancer - Introduction

      SEMINARS IN ONCOLOGY
    18. Tsukada, H; Yokoyama, A; Goto, K; Takada, M; Saijo, N
      Concurrent versus sequential radiotherapy for small cell lung cancer

      SEMINARS IN ONCOLOGY
    19. Yoshida, M; Feng, WJ; Nishio, K; Takahashi, M; Heike, Y; Saijo, N; Wakasugi, H; Ikekawa, T
      Antitumor action of the PKC activator gnidimacrin through cdk2 inhibition

      INTERNATIONAL JOURNAL OF CANCER
    20. Usuda, J; Okunaka, T; Furukawa, K; Tsuchida, T; Kuroiwa, Y; Ohe, Y; Saijo, N; Nishio, K; Konaka, C; Kato, H
      Increased cytotoxic effects of photodynamic therapy in IL-6 gene transfected cells via enhanced apoptosis

      INTERNATIONAL JOURNAL OF CANCER
    21. Heike, Y; Kasono, K; Kunisaki, C; Hama, S; Saijo, N; Tsuruo, T; Kuntz, DA; Rose, DR; Curiel, DT
      Overcoming multi-drug resistance using an intracellular anti-MDR1 sFv

      INTERNATIONAL JOURNAL OF CANCER
    22. Nishio, K; Nakamura, T; Koh, Y; Kanzawa, F; Tamura, T; Saijo, N
      Oncoprotein 18 overexpression Increases the sensitivity to vindesine in the Human hung Carcinoma Cells

      CANCER
    23. Kubota, K; Tamura, T; Fukuoka, M; Furuse, K; Ikegami, H; Ariyoshi, Y; Kurita, Y; Saijo, N
      Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: Long-term follow-up results. Japan Clinical Oncology Group Protocol 8902

      ANNALS OF ONCOLOGY
    24. Kuh, HJ; Nakagawa, S; Usuda, J; Yamaoka, K; Saijo, N; Nishio, K
      A computational model for quantitative analysis of cell cycle arrest and its contribution to overall growth inhibition by anticancer agents

      JAPANESE JOURNAL OF CANCER RESEARCH
    25. Yamamoto, N; Tamura, T; Kamiya, Y; Sekine, I; Kunitoh, H; Saijo, N
      Correlation between docetaxel clearance and estimated cytochrome P450 activity by urinary metabolite of exogenous cortisol

      JOURNAL OF CLINICAL ONCOLOGY
    26. Suzuki, T; Sasaki, H; Kuh, HJ; Agui, M; Tatsumi, Y; Tanabe, S; Terada, M; Saijo, N; Nishio, K
      Detailed structural analysis on both human MRP5 and mouse mrp5 transcripts

      GENE
    27. Kurata, T; Tamura, T; Sasaki, Y; Fujii, H; Negoro, S; Fukuoka, M; Saijo, N
      Pharmacokinetic and pharmacodynamic analysis of bis-acetato-ammine-dichloro-cyclohexylamine-platinum (JM216) administered once a day for five consecutive days: A phase I study

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    28. Nakamura, Y; Kunitoh, H; Kubota, K; Sekine, I; Shinkai, T; Tamura, T; Kodama, T; Sumi, M; Kohno, S; Saijo, N
      Platinum-based chemotherapy with or without thoracic radiation therapy in patients with unresectable thymic carcinoma

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    29. Sekine, I; Matsuda, T; Saisho, T; Watanabe, H; Yamamoto, N; Kunitoh, H; Ohe, Y; Tamura, T; Kodama, T; Saijo, N
      Bacterial meningitis observed in a phase I trial of vinorelbine, cisplatinand thoracic radiotherapy for non-small cell lung cancer: Report of a caseand discussion on dose-limiting toxicity

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    30. Fujishiro, M; Shinkai, T; Fukuda, M; Tamura, T; Ohe, Y; Kunitoh, H; Nishiwaki, Y; Sekine, I; Fukuda, H; Saijo, N
      Phase I study of a weekly infusion of irinotecan hydrochloride (CPT-11) and a 14-day continuous infusion of etoposide in patients with lung cancer: JCOG trial 9408

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    31. Nakamura, Y; Sekine, I; Furuse, K; Saijo, N
      Retrospective comparison of toxicity and efficacy in phase II trials of 3-h infusions of paclitaxel for patients 70 years of age or older and patients under 70 years of age

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    32. Saijo, N; Tamura, T; Nishio, K
      Problems in the development of target-based drugs

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    33. Fukuoka, K; Yamagishi, T; Ichihara, T; Nakaike, S; Iguchi, K; Yamada, Y; Fukumoto, H; Yoneda, T; Samata, K; Ikeya, H; Nanaumi, K; Hirayama, N; Narita, N; Saijo, N; Nishio, K
      Mechanism of action of aragusterol A (YTA0040), a potent anti-tumor marinesteroid targeting the G(1) phase of the cell cycle

      INTERNATIONAL JOURNAL OF CANCER
    34. Fukuoka, K; Nishio, K; Fukumoto, H; Arioka, H; Kurokawa, H; Ishida, T; Iwamoto, Y; Tomonari, A; Suzuki, T; Usuda, J; Narita, N; Saijo, N
      Ectopic p16(INK4) expression enhances CPT-11-induced apoptosis through increased delay in S-phase progression in human non-small-cell-lung-cancer cells

      INTERNATIONAL JOURNAL OF CANCER
    35. Usuda, J; Saijo, N; Fukuoka, K; Fukumoto, H; Kuh, HJ; Nakamura, T; Koh, Y; Suzuki, T; Koizumi, F; Tamura, T; Kato, H; Nishio, K
      Molecular determinants of UCN-01-induced growth inhibition in human lung cancer cells

      INTERNATIONAL JOURNAL OF CANCER
    36. Kurokawa, H; Nishio, K; Fukumoto, H; Tomonari, A; Suzuki, T; Saijo, N
      Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells

      ONCOLOGY REPORTS
    37. Yamamoto, N; Tamura, T; Yamamoto, N; Fukuoka, M; Saijo, N
      Survival and prognostic factors in lung cancer patients treated in phase Itrials: Japanese experience

      INTERNATIONAL JOURNAL OF ONCOLOGY
    38. Nishio, K; Fukuoka, K; Fukumoto, H; Sunami, T; Iwamoto, Y; Suzuki, T; Usuda, J; Saijo, N
      Mitogen-activated protein kinase antisense oligonucleotide inhibits the growth of human lung cancer cells

      INTERNATIONAL JOURNAL OF ONCOLOGY
    39. Sekine, I; Tamura, T; Kunitoh, H; Kubota, K; Shinkai, T; Kamiya, Y; Saijo, N
      Progressive disease rate as a surrogate endpoint of phase II trials for non-small-cell lung cancer

      ANNALS OF ONCOLOGY
    40. Arioka, H; Nishio, K; Ishida, T; Fukumoto, H; Fukuoka, K; Nomoto, T; Kurokawa, H; Yokote, H; Abe, S; Saijo, N
      Enhancement of cisplatin sensitivity in high mobility group 2 cDNA-transfected human lung cancer cells

      JAPANESE JOURNAL OF CANCER RESEARCH
    41. Okamoto, H; Watanabe, K; Nishiwaki, Y; Mori, K; Kurita, Y; Hayashi, I; Masutani, M; Nakata, K; Tsuchiya, S; Sobe, H; Saijo, N
      Phase II study of area under the plasma-concentration-versus-time curve-based carboplatin plus standard-dose intravenous etoposide in elderly patients with small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    42. Saijo, N
      Antiemetic therapy

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    43. Kanzawa, F; Nishio, K; Fukuoka, K; Sunami, T; Saijo, N
      In vitro interactions of a new derivative of spicamycin, KRN5500, and other anticancer drugs using a three-dimensional model

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    44. Sunami, T; Nishio, K; Kanzawa, F; Fukuoka, K; Kudoh, S; Yoshikawa, J; Saijo, N
      Combination effects of TAS-103, a novel dual topoisomerase I and II inhibitor, with other anticancer agents on human small cell lung cancer cells

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    45. Tanaka, T; Uchiumi, T; Nomoto, M; Kohno, K; Kondo, T; Nishio, K; Saijo, N; Kuwano, M
      Cellular balance of glutathione levels through the expression of gamma-glutamylcysteine synthetase and glutathione thiol transferase genes in human hepatic cells resistant to a glutathione poison

      BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
    46. Nishio, K; Saijo, N
      Cytoskeletons and antimitotic agents developed in Japan

      ANTI-CANCER DRUG DESIGN
    47. Fukumoto, H; Tamura, T; Kamiya, Y; Usuda, J; Suzuki, T; Kanzawa, F; Kuh, HJ; Ohe, Y; Saijo, N; Nishio, K
      Activation-induced apoptosis of peripheral lymphocytes treated with 7-hydroxystaurosporine, UCN-01

      INVESTIGATIONAL NEW DRUGS
    48. Fukumoto, H; Nishio, K; Ohta, S; Hanai, N; Fukuoka, K; Ohe, Y; Sugihara, K; Kodama, T; Saijo, N
      Effect of a chimeric anti-ganglioside GM2 antibody on ganglioside GM2-expressing human solid tumors in vivo

      INTERNATIONAL JOURNAL OF CANCER
    49. Kunitoh, H; Sekine, I; Kubota, K; Tamura, T; Shinkai, T; Kodama, T; Saijo, N; Naruke, T; Yamaguchi, N
      Histologic types of lung carcinoma and related family history of anatomic sites and histologic types of cancers

      CANCER
    50. SEKINE I; KUBOTA K; NISHIWAKI Y; SASAKI Y; TAMURA T; SAIJO N
      RESPONSE RATE AS AN END-POINT FOR EVALUATING NEW CYTOTOXIC AGENTS IN PHASE-II TRIALS OF NON-SMALL-CELL LUNG-CANCER

      Annals of oncology
    51. SAIJO N
      COMBINATION CHEMOTHERAPY WITH CAMPTOTHECINS

      Annals of oncology
    52. USUDA J; NISHIO K; FUKUOKA K; FUKUMOTO H; IWAMOTO Y; NARUSE S; SUZUKI T; KATO H; SAIJO N
      UCN-01 ACCUMULATES FUNCTIONAL P53 INTO THE NUCLEUS IN A PHORBOLESTER RESISTANT LEUKEMIA-CELL LINE AS A BASIS OF CYCLIN-DEPENDENT KINASE INHIBITION

      Annals of oncology
    53. Yokote, H; Nishio, K; Arioka, H; Kurokawa, H; Fukuoka, K; Fukumoto, H; Ishida, T; Terada, T; Itakura, T; Saijo, N
      The C-terminal domain of p53 catalyzes DNA-renaturation and strand exchange toward annealing between intact ssDNAs and toward eliminating damaged ssDNA from duplex formation through preferential recognition of damaged DNA bya duocarmycin

      MUTATION RESEARCH-DNA REPAIR
    54. Iwamoto, Y; Nishio, K; Fukumoto, H; Yoshimatsu, K; Yamakido, M; Saijo, N
      Preferential binding of E7010 to murine beta 3-tubulin and decreased beta 3-tubulin in E7010-resistant cell lines

      JAPANESE JOURNAL OF CANCER RESEARCH
    55. Nomoto, T; Nishio, K; Ishida, T; Mori, M; Saijo, N
      Characterization of a human small-cell lung cancer cell line resistant to a new water-soluble camptothecin derivative, DX-8951f

      JAPANESE JOURNAL OF CANCER RESEARCH
    56. SAIJO N; NISHIO K
      OVERCOMING DRUG-RESISTANCE IN LUNG-CANCER

      Oncology
    57. FURUSE K; FUKUOKA M; NISHIWAKI Y; KURITA Y; WATANABE K; NODA K; ARIYOSHI Y; TAMURA T; SAIJO N
      PHASE-III STUDY OF INTENSIVE WEEKLY CHEMOTHERAPY WITH RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR VERSUS STANDARD CHEMOTHERAPY IN EXTENSIVE-DISEASE SMALL-CELL LUNG-CANCER

      Journal of clinical oncology
    58. SEKINE I; FUKUDA H; KUNITOH H; SAIJO N
      CANCER-CHEMOTHERAPY IN THE ELDERLY

      Japanese Journal of Clinical Oncology
    59. SAIJO N
      PHARMACOKINETICS OF CISPLATIN AND COMBINATION CHEMOTHERAPY OF CISPLATIN PLUS 5-FU

      Japanese Journal of Clinical Oncology
    60. SHIMOYAMA M; FUKUDA H; SAIJO N; YAMAGUCHI N
      JAPAN CLINICAL ONCOLOGY GROUP (JCOG)

      Japanese Journal of Clinical Oncology
    61. KASAI T; OHE Y; NISHIO K; KUNITOH H; TAMURA T; SEKINE I; KUBOTA K; YAMAMOTO N; NAKAMURA Y; SHINKAI T; KODAMA T; SAIJO N
      FACTORS THAT INFLUENCE THE ELIGIBILITY OF CASES FOR INCLUSION IN CLINICAL-TRIALS

      Japanese Journal of Clinical Oncology
    62. Asamoto, H; Kawahara, M; Iwami, F; Kuba, M; Furuse, K; Tamura, T; Saijo, N; Shimoyama, M
      Cisplatin plus oral etoposide in the treatment of patients with advanced small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    63. Naruse, I; Heike, Y; Hama, S; Mori, M; Saijo, N
      High concentrations of recombinant adenovirus expressing p16 gene induces apoptosis in lung cancer cell lines

      ANTICANCER RESEARCH
    64. FUKUOKA K; NARITA N; SAIJO N
      INCREASED EXPRESSION OF SIALYL LEWIS(X) ANTIGEN IS ASSOCIATED WITH DISTANT METASTASIS IN LUNG-CANCER PATIENTS - IMMUNOHISTOCHEMICAL STUDY ON BRONCHOFIBERSCOPIC BIOPSY SPECIMENS

      Lung cancer
    65. TADA T; KAWASE I; NEGORO S; KURITA Y; TAMURA T; SAIJO N
      PROPHYLACTIC CRANIAL IRRADIATION (PCI) IN PATIENTS WITH PROLONGED SURVIVAL IN LIMITED SMALL-CELL LUNG-CANCER (L-SCLC)

      Radiology
    66. FUJIMORI K; YOKOYAMA A; KURITA Y; UNO K; SAIJO N
      PACLITAXEL-INDUCED CELL-MEDIATED HYPERSENSITIVITY PNEUMONITIS - DIAGNOSIS USING LEUKOCYTE MIGRATION TEST, BRONCHOALVEOLAR LAVAGE AND TRANSBRONCHIAL LUNG-BIOPSY

      Oncology
    67. YOSHIDA M; YOKOKURA K; HIDAKA H; IKEKAWA T; SAIJO N
      MECHANISM OF ANTITUMOR ACTION OF PKC ACTIVATOR, GNIDIMACRIN

      International journal of cancer
    68. HAMA S; HEIKE Y; NARUSE I; TAKAHASHI M; YOSHIOKA H; ARITA K; KURISU K; GOLDMAN CK; CURIEL DT; SAIJO N
      ADENOVIRUS-MEDIATED P16 GENE-TRANSFER PREVENTS DRUG-INDUCED CELL-DEATH THROUGH G(1) ARREST IN HUMAN GLIOMA-CELLS

      International journal of cancer
    69. CHEN ZS; MUTOH M; SUMIZAWA T; FURUKAWA T; HARAGUCHI M; TANI A; SAIJO N; KONDO T; AKIYAMA SI
      AN ACTIVE EFFLUX SYSTEM FOR HEAVY-METALS IN CISPLATIN-RESISTANT HUMANKB CARCINOMA-CELLS

      Experimental cell research
    70. SAIJO N
      NEW CHEMOTHERAPEUTIC-AGENTS FOR THE TREATMENT OF NONSMALL CELL LUNG-CANCER - THE JAPANESE EXPERIENCE

      Chest
    71. MINAMI H; SASAKI Y; SAIJO N; OHTSU T; FUJII H; IGARASHI T; ITOH K
      INDIRECT-RESPONSE MODEL FOR THE TIME-COURSE OF LEUKOPENIA WITH ANTICANCER DRUGS

      Clinical pharmacology and therapeutics
    72. YOKOYAMA A; KURITA Y; SAIJO N; TAMURA T; NODA K; SHIMOKATA K; MATSUDA T
      DOSE-FINDING STUDY OF IRINOTECAN AND CISPLATIN PLUS CONCURRENT RADIOTHERAPY FOR UNRESECTABLE STAGE-III NON-SMALL-CELL LUNG-CANCER

      British Journal of Cancer
    73. FURUSE K; KAWAHARA M; NISHIWAKI Y; HORAI T; SAIJO N; HASEGAWA K; OKISHIO K; NIITANI H
      RANDOMIZED STUDY OF VINORELBINE OR VINDESINE WITH CISPLATIN AND MITOMYCIN AS INDUCTION CHEMOTHERAPY IN NSCLC

      British Journal of Cancer
    74. KUNITOH H; SAIJO N; FURUSE K; NODA K; OGAWA M
      NEUROMUSCULAR TOXICITIES OF PACLITAXEL 210 MG M(-2) BY 3-HOUR INFUSION

      British Journal of Cancer
    75. TANAKA T; UCHIUMI T; KOHNO K; TOMONARI A; NISHIO K; SAIJO N; KONDO T; KUWANO M
      GLUTATHIONE HOMEOSTASIS IN HUMAN HEPATIC CELLS - OVEREXPRESSION OF GAMMA-GLUTAMYLCYSTEINE SYNTHETASE GENE IN CELL-LINES RESISTANT TO BUTHIONINE SULFOXIMINE, AN INHIBITOR OF GLUTATHIONE SYNTHESIS

      Biochemical and biophysical research communications
    76. YAMAMOTO N; TAMURA T; NISHIWAKI Y; KURITA Y; KAWAKAMI Y; ABE S; NAKABAYASHI T; SUZUKI S; MATSUDA T; HAYASHI I; TAKAHASHI T; SAIJO N
      LIMITED SAMPLING MODEL FOR THE AREA UNDER THE CONCENTRATION VERSUS TIME CURVE OF IRINOTECAN AND ITS APPLICATION TO A MULTICENTRIC PHASE-II TRIAL

      Clinical cancer research
    77. OKUSAKA T; EGUCHI K; KASAI T; KURATA T; YAMAMOTO N; OHE Y; TAMURA T; SHINKAI T; SAIJO N
      SERUM LEVELS OF PRO-GASTRIN-RELEASING PEPTIDE FOR FOLLOW-UP OF PATIENTS WITH SMALL-CELL LUNG

      Clinical cancer research
    78. HEIKE Y; TAKAHASHI M; KANEGAE Y; SATO Y; SAITO I; SAIJO N
      INTERLEUKIN-2 GENE TRANSDUCTION INTO FRESHLY ISOLATED LUNG ADENOCARCINOMA CELLS WITH ADENOVIRAL VECTORS

      Human gene therapy
    79. BUNN P; CARBONE D; GRIM J; HARRIS C; HAVEMANN K; MABRY M; ROTH J; SAIJO N; POULSEN HS; STAHEL R; TAKAHASHI T; TWENTYMAN P
      5TH IASLC LUNG-TUMOR BIOLOGY WORKSHOP, AUGUST 13-17, 1996, ERMATINGEN, SWITZERLAND

      Annals of oncology
    80. FUKUMOTO H; NISHIO M; NISHIO K; HEIKE Y; ARIOKA H; KUROKAWA H; ISHIDA T; FUKUOKA K; NOMOTO T; OHE Y; SAIJO N
      INTERFERON-GAMMA-INDUCING FACTOR GENE TRANSFECTION INTO LEWIS-LUNG-CARCINOMA CELLS REDUCES TUMORIGENICITY IN-VIVO

      Japanese journal of cancer research
    81. KUROKAWA H; NISHIO K; ISHIDA T; ARIOKA H; FUKUOKA K; NOMOTO T; FUKUMOTO H; YOKOTE H; SAIJO N
      EFFECT OF GLUTATHIONE DEPLETION ON CISPLATIN RESISTANCE IN CANCER-CELLS TRANSFECTED WITH THE GAMMA-GLUTAMYLCYSTEINE SYNTHETASE GENE

      Japanese journal of cancer research
    82. OGASAWARA H; NISHIO K; ISHIDA T; ARIOKA H; FUKUOKA K; SAIJO N
      IN-VITRO ENHANCEMENT OF ANTITUMOR-ACTIVITY OF A WATER-SOLUBLE DUOCARMYCIN DERIVATIVE, KW-2189, BY CAFFEINE-MEDIATED DNA-REPAIR INHIBITION IN HUMAN LUNG-CANCER CELLS

      Japanese journal of cancer research
    83. FUKUOKA K; ADACHI J; NISHIO K; ARIOKA H; KUROKAWA H; FUKUMOTO H; ISHIDA T; NOMOTO T; YOKOTE H; TOMONARI A; NARITA N; YOKOTA J; SAIJO N
      P16(INK4) EXPRESSION IS ASSOCIATED WITH THE INCREASED SENSITIVITY OF HUMAN NONSMALL CELL LUNG-CANCER CELLS TO DNA TOPOISOMERASE-I INHIBITORS

      Japanese journal of cancer research
    84. OSHITA F; NODA K; NISHIWAKI Y; FUJITA A; KURITA Y; NAKABAYASHI T; TOBISE K; ABE S; SUZUKI S; HAYASHI I; KAWAKAMI Y; MATSUDA T; TSUCHIYA S; TAKAHASHI S; TAMURA T; SAIJO N
      PHASE-II STUDY OF IRINOTECAN AND ETOPOSIDE IN PATIENTS WITH METASTATIC NON-SMALL-CELL LUNG-CANCER

      Journal of clinical oncology
    85. KAWAHARA M; FUKUOKA M; SAIJO N; NISHIWAKI Y; IKEGAMI H; TAMURA T; SHIMOYAMA M; SUEMASU K; FURUSE K
      PROGNOSTIC FACTORS AND PROGNOSTIC STAGING SYSTEM FOR SMALL-CELL LUNG-CANCER

      Japanese Journal of Clinical Oncology
    86. NEGORO S; MASUDA N; FURUSE K; SAIJO N; FUKUOKA M
      DOSE-INTENSIVE CHEMOTHERAPY IN EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER

      Cancer chemotherapy and pharmacology
    87. SAIJO N
      CHEMOTHERAPY - THE MORE THE BETTER - OVERVIEW

      Cancer chemotherapy and pharmacology
    88. HAMA S; SADATOMO T; YOSHIOKA H; KURISU K; TAHARA E; NARUSE I; HEIKE Y; SAIJO N
      TRANSFORMATION OF HUMAN GLIOMA CELL-LINES WITH THE P16 GENE INHIBITS CELL-PROLIFERATION

      Anticancer research
    89. YAMAMOTO N; TAMURA T; OHE Y; OSHITA F; KASAI T; KURATA T; SHINKAI T; EGUCHI K; SAIJO N
      CHRONOPHARMACOLOGY OF ETOPOSIDE GIVEN BY LOW-DOSE PROLONGED INFUSION IN LUNG-CANCER PATIENTS

      Anticancer research
    90. ARIOKA H; NISHIO K; HEIKE Y; ABE S; SAIJO N
      IN-VITRO AND IN-VIVO MODULATION BY RHIZOXIN OF NON-P-GLYCOPROTEIN-MEDIATED VINDESINE RESISTANCE

      Journal of cancer research and clinical oncology
    91. IHDE D; SOUHAMI B; COMIS R; GREGOR A; HANSEN H; JOHNSON B; MURRAY N; POSTMUS P; ROCMANS P; SAIJO N; STOUT R; TURRISI A; WAGNER H
      SMALL-CELL LUNG-CANCER

      Lung cancer
    92. BUNN P; CARBONE D; GRIM J; HARRIS C; HAVEMANN K; MABRY M; ROTH J; SAIJO N; POULSEN HS; STAHEL R; TAKAHASHI T
      5TH IASLC LUNG-TUMOR BIOLOGY WORKSHOP, AUGUST 13-17, 1996, ERMATINGEN, SWITZERLAND

      Lung cancer
    93. KANZAWA F; SAIJO N
      IN-VITRO INTERACTION BETWEEN GEMCITABINE AND OTHER ANTICANCER DRUGS USING A NOVEL 3-DIMENSIONAL MODEL

      Seminars in oncology
    94. HEIKE Y; TAKAHASHI M; OHIRA T; NARUSE I; HAMA S; OHE Y; KASAI T; FUKUMOTO H; OLSEN KJ; PODACK EE; SAIJO N
      GENETIC IMMUNOTHERAPY BY INTRAPLEURAL, INTRAPERITONEAL AND SUBCUTANEOUS INJECTION OF IL-2 GENE-MODIFIED LEWIS LUNG-CARCINOMA CELLS

      International journal of cancer
    95. ISHIDA T; NISHIO K; KUROKAWA H; ARIOKA H; FUKUMOTO H; FUKUOKA K; NOMOTO T; YOKOTE H; HASEGAWA S; SAIJO N
      CIRCUMVENTION OF GLUTATHIONE-MEDIATED MITOMYCIN-C RESISTANCE BY A NOVEL MITOMYCIN-C ANALOG, KW-2149

      International journal of cancer
    96. KANZAWA F; NISHIO K; FUKUOKA K; FUKUDA M; KUNIMOTO T; SAIJO N
      EVALUATION OF SYNERGISM BY A NOVEL 3-DIMENSIONAL MODEL FOR THE COMBINED ACTION OF CISPLATIN AND ETOPOSIDE ON THE GROWTH OF A HUMAN SMALL-CELL LUNG-CANCER CELL-LINE, SBC-3

      International journal of cancer
    97. KANZAWA F; NISHIO K; ISHIDA T; FUKUDA M; KUROKAWA H; FUKUMOTO H; NOMOTO Y; FUKUOKA K; BOJANOWSKI K; SAIJO N
      ANTITUMOR ACTIVITIES OF A NEW BENZO[C]PHENANTHRIDINE AGENT, METHYL-7-HYDROXY-8-METHOXYBENZO[C]PHENANTHRIDINIUM HYDROGENSULFATE DIHYDRATE (NK109), AGAINST SEVERAL DRUG-RESISTANT HUMAN TUMOR-CELL LINES

      British Journal of Cancer
    98. ANDO M; EGUCHI K; SHINKAI T; TAMURA T; OHE Y; YAMAMOTO N; KURATA T; KASAI T; OHMATSU H; KUBOTA K; SEKINE I; HOJO N; MATSUMOTO T; KODAMA T; KAKINUMA R; NISHIWAKI Y; SAIJO N
      PHASE-I STUDY OF SEQUENTIALLY ADMINISTERED TOPOISOMERASE-I INHIBITOR (IRINOTECAN) AND TOPOISOMERASE-II INHIBITOR (ETOPOSIDE) FOR METASTATICNON-SMALL-CELL LUNG-CANCER

      British Journal of Cancer
    99. SUZUKI T; NISHIO K; SASAKI H; IKEUCHI T; TANABE S; TERADA M; SAIJO N
      CDNA CLONING OF A SHORT TYPE OF MULTIDRUG-RESISTANCE PROTEIN HOMOLOG,SMRP, FROM A HUMAN LUNG-CANCER CELL-LINE

      Biochemical and biophysical research communications
    100. TOMONARI A; NISHIO K; KUROKAWA H; FUKUMOTO H; FUKUOKA K; IWAMOTO Y; USUDA J; SUZUKI T; ITAKURA M; SAIJO N
      PROXIMAL 5'-FLANKING SEQUENCE OF THE HUMAN GAMMA-GLUTAMYLCYSTEINE SYNTHETASE HEAVY SUBUNIT GENE IS INVOLVED IN CISPLATIN-INDUCED TRANSCRIPTIONAL UP-REGULATION IN A LUNG-CANCER CELL-LINE SBC-3

      Biochemical and biophysical research communications


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/08/20 alle ore 01:14:23